Mass High Tech -- Syndax Pharmaceuticals Inc., a cancer therapeutics developer in Waltham, has raised $6 million of a planned $7 million securities offering, according to a regulatory filing from Wednesday.
Mass High Tech -- Syndax Pharmaceuticals Inc., a cancer therapeutics developer in Waltham, has raised $6 million of a planned $7 million securities offering, according to a regulatory filing from Wednesday.
